Literature DB >> 1576851

Pulmonary hemodynamics and physical training in patients with chronic obstructive pulmonary disease.

T K Rogers1, P Howard.   

Abstract

The main hemodynamic abnormality in COPD is raised pulmonary vascular resistance and pulmonary hypertension. This is particularly evident when the vascular bed is stressed as in exercise; the absence of reserve collateral vessels prevents the normal reduction in pulmonary vascular resistance, and hence, pressure increases with flow. The increased afterload reduces right ventricular ejection fraction and stroke volume, but cardiac output is maintained by a relative tachycardia. Although most patients have a ventilatory limitation to exercise, in the later stages of the disease, hemodynamic factors may contribute. Studies of the effects of physical training on pulmonary hemodynamics have been few but none has shown any significant improvement. Occasionally there may be an increase in arteriovenous oxygen difference, accounting for the increase in symptom-limited oxygen consumption seen in some patients. The absence of hemodynamic effects of training may be due to insufficient training intensity. The often impressive increases in work tolerance after training may be due in part to an increase in muscular coordination and technique, as well as to metabolic training effects and psychologic factors.

Entities:  

Mesh:

Year:  1992        PMID: 1576851     DOI: 10.1378/chest.101.5_supplement.289s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  2 in total

1.  Using computer-based medical records to predict mortality risk for inner-city patients with reactive airways disease.

Authors:  W M Tierney; M D Murray; D L Gaskins; X H Zhou
Journal:  J Am Med Inform Assoc       Date:  1997 Jul-Aug       Impact factor: 4.497

2.  Changes in pulmonary vascular tone during exercise. Effects of nitric oxide (NO) synthase inhibition, L-arginine infusion, and NO inhalation.

Authors:  T Koizumi; R Gupta; M Banerjee; J H Newman
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.